This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Stroke, Vol 14, 99-103, Copyright © 1983 by American Heart Association

ARTICLES

Persantine Aspirin Trial in cerebral ischemia. The American-Canadian Co- operative Study Group

The Persantine Aspirin Trial is a double-blind multi-centered cooperative study focusing primarily on the question of whether the administration of the combination of aspirin and dipyridamole (Persantine) will result in a greater reduction of cerebral or retinal infarction or death than the administration of aspirin alone. Fifteen centers in the United States and Canada are participating. More than 750 individuals with a history of recent carotid territory transient ischemic attacks (TIAs) have been admitted over the past four years and randomly allocated to either aspirin (325 mg) plus placebo four times daily or aspirin (325 mg) plus Persantine (75 mg) four times daily. It is anticipated that the study will continue through 1983. Analysis and publication of results are planned for 1984.

This article has been cited by other articles:

				L. C. Pettigrew William Straus Fields, MD (1913-2004) Neurology, August 10, 2004; 63(3): 416 - 417. [Full Text] [PDF]

				G. Agnelli Rationale for the use of platelet aggregation inhibitors in PAD patients Vascular Medicine, February 1, 2001; 6(1_suppl): 13 - 15. [Abstract] [PDF]

				G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Chest, January 1, 2001; 119(1_suppl): 300S - 320S. [Full Text] [PDF]

				J. L. Wilterdink and J. D. Easton Dipyridamole Plus Aspirin in Cerebrovascular Disease Arch Neurol, September 1, 1999; 56(9): 1087 - 1092. [Abstract] [Full Text] [PDF]

				Antiplatelet Trialists Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ, January 8, 1994; 308(6921): 81 - 106. [Abstract] [Full Text]

				W. R. Slade JR., S. Raguthu, R. Borras, J.R. Chen, and A. Alperovich T.I.A. Revisited: New Wine Old Bottle Angiology, May 1, 1986; 37(5): 365 - 371. [Abstract] [PDF]